248 related articles for article (PubMed ID: 23293738)
1. Polyamine-based small molecule epigenetic modulators.
Sharma SK; Hazeldine S; Crowley ML; Hanson A; Beattie R; Varghese S; Senanayake TM; Hirata A; Hirata F; Huang Y; Wu Y; Steinbergs N; Murray-Stewart T; Bytheway I; Casero RA; Woster PM
Medchemcomm; 2012; 3(1):14-21. PubMed ID: 23293738
[TBL] [Abstract][Full Text] [Related]
2. Polyamine analogues targeting epigenetic gene regulation.
Huang Y; Marton LJ; Woster PM; Casero RA
Essays Biochem; 2009 Nov; 46():95-110. PubMed ID: 20095972
[TBL] [Abstract][Full Text] [Related]
3. The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines.
Murray-Stewart T; Woster PM; Casero RA
Amino Acids; 2014 Mar; 46(3):585-94. PubMed ID: 23508577
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
Vasilatos SN; Katz TA; Oesterreich S; Wan Y; Davidson NE; Huang Y
Carcinogenesis; 2013 Jun; 34(6):1196-207. PubMed ID: 23354309
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1.
Hazeldine S; Pachaiyappan B; Steinbergs N; Nowotarski S; Hanson AS; Casero RA; Woster PM
J Med Chem; 2012 Sep; 55(17):7378-91. PubMed ID: 22876979
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells.
Huang Y; Vasilatos SN; Boric L; Shaw PG; Davidson NE
Breast Cancer Res Treat; 2012 Feb; 131(3):777-89. PubMed ID: 21452019
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment.
Duan YC; Ma YC; Qin WP; Ding LN; Zheng YC; Zhu YL; Zhai XY; Yang J; Ma CY; Guan YY
Eur J Med Chem; 2017 Nov; 140():392-402. PubMed ID: 28987602
[TBL] [Abstract][Full Text] [Related]
8. (Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators.
Sharma SK; Wu Y; Steinbergs N; Crowley ML; Hanson AS; Casero RA; Woster PM
J Med Chem; 2010 Jul; 53(14):5197-212. PubMed ID: 20568780
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer.
Duan YC; Jin LF; Ren HM; Zhang SJ; Liu YJ; Xu YT; He ZH; Song Y; Yuan H; Chen SH; Guan YY
Eur J Med Chem; 2021 Aug; 220():113453. PubMed ID: 33957387
[TBL] [Abstract][Full Text] [Related]
10. Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitors.
Milelli A; Marchetti C; Turrini E; Catanzaro E; Mazzone R; Tomaselli D; Fimognari C; Tumiatti V; Minarini A
Bioorg Med Chem Lett; 2018 Apr; 28(6):1001-1004. PubMed ID: 29496367
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.
Singh MM; Manton CA; Bhat KP; Tsai WW; Aldape K; Barton MC; Chandra J
Neuro Oncol; 2011 Aug; 13(8):894-903. PubMed ID: 21653597
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel cyclic Peptide inhibitors of lysine-specific demethylase 1.
Kumarasinghe IR; Woster PM
ACS Med Chem Lett; 2014 Jan; 5(1):29-33. PubMed ID: 24883177
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes.
Huang Y; Greene E; Murray Stewart T; Goodwin AC; Baylin SB; Woster PM; Casero RA
Proc Natl Acad Sci U S A; 2007 May; 104(19):8023-8. PubMed ID: 17463086
[TBL] [Abstract][Full Text] [Related]
14. Natural products as LSD1 inhibitors for cancer therapy.
Fang Y; Yang C; Yu Z; Li X; Mu Q; Liao G; Yu B
Acta Pharm Sin B; 2020 Jun; 11(3):621-31. PubMed ID: 32837872
[TBL] [Abstract][Full Text] [Related]
15. Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes.
Huang Y; Stewart TM; Wu Y; Baylin SB; Marton LJ; Perkins B; Jones RJ; Woster PM; Casero RA
Clin Cancer Res; 2009 Dec; 15(23):7217-28. PubMed ID: 19934284
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel, potent, and orally bioavailable HDACs inhibitors with LSD1 inhibitory activity for the treatment of solid tumors.
Duan Y; Yu T; Jin L; Zhang S; Shi X; Zhang Y; Zhou N; Xu Y; Lu W; Zhou H; Zhu H; Bai S; Hu K; Guan Y
Eur J Med Chem; 2023 Jun; 254():115367. PubMed ID: 37086699
[TBL] [Abstract][Full Text] [Related]
17. Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG.
Anastas JN; Zee BM; Kalin JH; Kim M; Guo R; Alexandrescu S; Blanco MA; Giera S; Gillespie SM; Das J; Wu M; Nocco S; Bonal DM; Nguyen QD; Suva ML; Bernstein BE; Alani R; Golub TR; Cole PA; Filbin MG; Shi Y
Cancer Cell; 2019 Nov; 36(5):528-544.e10. PubMed ID: 31631026
[TBL] [Abstract][Full Text] [Related]
18. LSD1 coordinates with the SIN3A/HDAC complex and maintains sensitivity to chemotherapy in breast cancer.
Yang Y; Huang W; Qiu R; Liu R; Zeng Y; Gao J; Zheng Y; Hou Y; Wang S; Yu W; Leng S; Feng D; Wang Y
J Mol Cell Biol; 2018 Aug; 10(4):285-301. PubMed ID: 29741645
[TBL] [Abstract][Full Text] [Related]
19. Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells.
Zhu Q; Huang Y; Marton LJ; Woster PM; Davidson NE; Casero RA
Amino Acids; 2012 Feb; 42(2-3):887-98. PubMed ID: 21805138
[TBL] [Abstract][Full Text] [Related]
20. Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases.
Mao F; Shi YG
Adv Exp Med Biol; 2023; 1433():15-49. PubMed ID: 37751134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
